List of Kite Pharma, Inc. patents

List of Kite Pharma, Inc. patents

List of CBRITE patents

List of RedSky Technologies patents

List of Michigan Critical Care Consultants, Inc. patents

Films directed by Phil Rosen

List of SBIR/STTR awards granted to ZIVA CORPORATION

Patents where

Current Assignee

Name

is

‌

Kite Pharma, Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11572388 Chimeric polypeptides and uses thereof	Patent 11572388 was granted and assigned to Kite Pharma, Inc. on February, 2023 by the United States Patent and Trademark Office.	‌ Kite Pharma, Inc.	‌ Kite Pharma, Inc.		United States Patent and Trademark Office	11572388	February 7, 2023
	‌ US Patent 11384155 Antigen binding molecules specific for an anti-CD19 scFv		‌ Kite Pharma, Inc.	‌ Kite Pharma, Inc.		United States Patent and Trademark Office	11384155	July 12, 2022
	‌ US Patent 11505613 BCMA binding molecules and methods of use thereof		‌ Kite Pharma, Inc.	‌ Kite Pharma, Inc.		United States Patent and Trademark Office	11505613	November 22, 2022
	‌ US Patent 11390655 Modified chimeric antigen receptors and methods of use	Patent 11390655 was granted and assigned to Kite Pharma, Inc. on July, 2022 by the United States Patent and Trademark Office.	‌ Kite Pharma, Inc.	‌ Kite Pharma, Inc.		United States Patent and Trademark Office	11390655	July 19, 2022
	‌ US Patent 11357796 Treatment using chimeric receptor T cells incorporating optimized polyfunctional T cells		‌ Kite Pharma, Inc.	‌ Kite Pharma, Inc.		United States Patent and Trademark Office	11357796	June 14, 2022
	‌ US Patent 11608517 Antigen binding molecules and methods of use thereof	Patent 11608517 was granted and assigned to Kite Pharma, Inc. on March, 2023 by the United States Patent and Trademark Office.	‌ Kite Pharma, Inc.	‌ Kite Pharma, Inc.		United States Patent and Trademark Office	11608517	March 21, 2023
	‌ US Patent 10603380 Chimeric antigen and T cell receptors and methods of use	Patent 10603380 was granted and assigned to Kite Pharma, Inc. on March, 2020 by the United States Patent and Trademark Office.	‌ Kite Pharma, Inc.	‌ Kite Pharma, Inc.		United States Patent and Trademark Office	10603380	March 31, 2020
	‌ US Patent 10501775 Antigen binding molecules and methods of use thereof	Patent 10501775 was granted and assigned to Kite Pharma, Inc. on December, 2019 by the United States Patent and Trademark Office.	‌ Kite Pharma, Inc.	‌ Kite Pharma, Inc.		United States Patent and Trademark Office	10501775	December 10, 2019
	‌ US Patent 10626187 Antigen binding molecules specific for an anti-CD19 scFv	Patent 10626187 was granted and assigned to Kite Pharma, Inc. on April, 2020 by the United States Patent and Trademark Office.	‌ Kite Pharma, Inc.	‌ Kite Pharma, Inc.		United States Patent and Trademark Office	10626187	April 21, 2020
	‌ US Patent 10844120 Humanized antigen-binding domains and methods of use		‌ Kite Pharma, Inc.	‌ Kite Pharma, Inc.		United States Patent and Trademark Office	10844120	November 24, 2020
	‌ US Patent 11046775 CD70 binding molecules and methods of use thereof	Patent 11046775 was granted and assigned to Kite Pharma, Inc. on June, 2021 by the United States Patent and Trademark Office.	‌ Kite Pharma, Inc.	‌ Kite Pharma, Inc.		United States Patent and Trademark Office	11046775	June 29, 2021
	‌ US Patent 10844371 Antigen binding molecules and methods of use thereof	Patent 10844371 was granted and assigned to Kite Pharma, Inc. on November, 2020 by the United States Patent and Trademark Office.	‌ Kite Pharma, Inc.	‌ Kite Pharma, Inc.		United States Patent and Trademark Office	10844371	November 24, 2020
	‌ US Patent 10689450 BCMA binding molecules and methods of use thereof		‌ Kite Pharma, Inc.	‌ Kite Pharma, Inc.		United States Patent and Trademark Office	10689450	June 23, 2020
	‌ US Patent 11129872 Methods of making and using soluble MHC molecules	Patent 11129872 was granted and assigned to Kite Pharma, Inc. on September, 2021 by the United States Patent and Trademark Office.	‌ Kite Pharma, Inc.	‌ Kite Pharma, Inc.		United States Patent and Trademark Office	11129872	September 28, 2021
	‌ US Patent 11834654 Antigen binding molecules and methods of use thereof	Patent 11834654 was granted and assigned to Kite Pharma, Inc. on December, 2023 by the United States Patent and Trademark Office.	‌ Kite Pharma, Inc.	‌ Kite Pharma, Inc.		United States Patent and Trademark Office	11834654	December 5, 2023
	‌ US Patent 12109235 TGF-beta receptors and methods of use	Patent 12109235 was granted and assigned to Kite Pharma, Inc. on October, 2024 by the United States Patent and Trademark Office.	‌ Kite Pharma, Inc.	‌ Kite Pharma, Inc.		United States Patent and Trademark Office	12109235	October 8, 2024
	‌ US Patent 11708401 Chimeric transmembrane proteins and uses thereof		‌ Kite Pharma, Inc.	‌ Kite Pharma, Inc.		United States Patent and Trademark Office	11708401	July 25, 2023

17 results

0 selected

17 results

0 selected